Dupuytren

What is Dupuytren Disease?
By: Charles Eaton
Jul 28, 2017

What is Dupuytren disease? After passing the first hurdle of pronouncing Dupuytren (DOOpa-tren: sort of rhymes with “hooka den”, “group of friends” “move again” “super bend”…), most people – doctors and patients alike – have trouble answering this question. Most doctors don’t give a simple answer. Instead, they often just describe some part of the problem. […]

Read more ›
Dupuytren and nerve problems?

Does Dupuytren cause nerve problems? A common topic of discussion on Dupuytren forums such The Dupuytren’s Disease Support Group is whether or not Dupuytren causes numbness and tingling in the hands and arms. As with everything Dupuytren related, the answer is …it depends. A few small studies suggesting that local tenderness in Dupuytren cords, nodules, […]

Read more ›
Dupuytren Disease Awareness Day!
On: Mar 20, 2017
By: Charles Eaton

Dupuytren Awareness Dupuytren disease research has a big problem: lack of awareness. Most people have never heard the word “Dupuytren”, much less “Dupuytren Disease”. The name “Dupuytren” is hard to pronounce and even harder to spell. Many other medical conditions have had this problem. Most have still not made it out into public. It takes work, […]

Read more ›
Cannabinoids, Dupuytren, and Orphan Drugs
On: Mar 3, 2017
By: Charles Eaton

I was recently asked if medical marijuana might be helpful for Dupuytren disease. The short answer is “No one knows.”. The longer answer is much more interesting. The late effect of Dupuytren disease is Dupuytren contracture. The medical term for the findings in Dupuytren contracture is fibrosis. Sclerosis also means the same thing. If either of […]

Read more ›
Happy Valentine’s Day from Dupuytren Research Group!
On: Feb 14, 2017
By: Charles Eaton

Two Dupuytren stories for this Valentine’s Day. First, Saint Valentine. There were nearly a dozen people called Saint Valentine. Did this one have Dupuytren Contracture? He’s clearly in the high risk demographic – an old Caucasian man. Looks like he’s got it, but we’ll never know. It is important to know that there’s a lot […]

Read more ›
The Future is Coming!

Improving the Future of Dupuytren Care Right now, many people with mild Dupuytren biology do well after surgery or after Xiaflex – because most people have mild to moderate Dupuytren biology. The issue isn’t the patient with mild disease biology who will do well for a long time after any treatment. The issue is those […]

Read more ›
Happy Thanksgiving from the Dupuytren Foundation!

Turkey Day Update! Much has happened since the last Dupuytren Foundation report in July. The International Dupuytren Data Bank (IDDB) averages 100 new enrollees each month. We’re continuing to work out the complicated details of blood testing. If you haven’t enrolled yet, now is the time: http://DupStudy.com. Our international research committee continues to grow. So does […]

Read more ›
Dupuytren’s Disease Support Group Q&A
On: Sep 2, 2016
By: Charles Eaton

Dupuytren disease research questions and answers. Dupuytren advocacy is challenging. One challenge is that many people have never heard the words Dupuytren, or Ledderhose, or Peyronie, including many who have these problems. A larger challenge is that no one knows the root biology of Dupuytren/Ledderhose/Peyronie disease – how it starts, or how to make it […]

Read more ›
Coffee for Dupuytren?
On: Aug 29, 2016
By: Charles Eaton

A recent study reported possible beneficial effects of caffeine on Dupuytren biology . There was 2011 study which reported similar results with forskolin, which affects the same cell chemistry as caffeine . Based on this, the possible use of caffeine was discussed in the Dupuytren Foundation blog in 2011 . Let’s look at two points in […]

Read more ›